查詢結果分析
來源資料
相關文獻
- 高脂血性胰臟炎施行血漿交換療法之血中物質清除效果研究
- 極低體重兒使用中鍵/長鍵三酸甘油脂靜脈營養的效果評估
- Blood Lipid Distrbution in Patients with Newly-Diagnosed, Non-Insulin-Dependent Diabetes Mellitus
- Newly Identified Missense Mutation Reduces Lipoprotein Lipase Activity in Taiwanese Patients with Hypertriglyceridemia
- 血漿分離術療法之併發症
- 治療性血漿分離/交換術在小兒疾病上之應用
- 血漿交換術--神經疾病治療之應用
- Hypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan
- DNA Polymorphisms at the Apolipoprotein A1-CIII Loci in Taiwanese: Correlation of Plasma ApoCIII with Triglyceride Level and Body Mass Index
- Effects of Fenofibrate and Gemfibrozil in Ethnic Chinese with Type IIb Dyslipidemia
頁籤選單縮合
題 名 | 高脂血性胰臟炎施行血漿交換療法之血中物質清除效果研究=Clearance Study for Hyperlipidemic Pancreatitis Treated by Plasma Exchange |
---|---|
作 者 | 葉建宏; 李美芬; 邱浩彰; 陳瑞灝; | 書刊名 | 輔仁醫學期刊 |
卷 期 | 2:2 2004.06[民93.06] |
頁 次 | 頁39-46 |
分類號 | 415.38 |
關鍵詞 | 血漿交換術; 三酸甘油脂; 高脂血性胰臟炎; Plasma exchange; Triglyceride; Hyperlipidemic pancreatitis; |
語 文 | 中文(Chinese) |
中文摘要 | 背景和目地:當血中三酸甘油脂濃度大於1000mg/dl時,即有可能併發胰臟炎之危險。本研究計畫評估血漿交換治療對血中三酸甘油脂濃度大於1000mg/d且合併急性胰臟炎之高脂血性胰臟炎血中物質之清除效果。方法:8例高脂血性胰臟炎,接受每天一次,連續兩天之血漿交換治療。結果:單次血漿交換治療下三酸甘油脂、膽固醇、澱粉酵素及解脂酵素之平均清除率分別為63.0%,53.7%,62.9%及68.8%。連續兩次治療下之平均清除率可增加至83.3%,62.9%,79.6%及80.4%。在第一次血漿交換後,除一例外,其餘7例皆已降至1000mg/dl以下。在全部16次血漿交換治療中有2次因穿膜壓過高引發溶血現象。併發症部分,輸注新鮮冷凍血漿之7例中除一例(個案4)外皆出現輸液相關併發症,其中畏寒出現3次,出現8次不適反應。三酸甘油脂及膽固醇之清除率分別與該物質治療前濃度成正相關(分別為p=0.0238及p=0.0117)。開始血漿交換治療天數與解脂酵素及澱粉酵素清除率皆呈有意義負相關(分別為p=0.0062及p=0.0413)。結論:對大部份高脂血性胰臟炎病人而言單次血漿交換應足已清除大部份之血中致病物質。另外,早期血漿交換治療有助於胰臟酵素之清除。血漿交換輸液部份,如無凝血障礙之考量,白蛋白溶液為較安全之輸液。 |
英文摘要 | Backgroud and Purpose: Patients with triglyceride levels over 1000 mg/dl are at high risk of developing acute pancreatitis. This study aimed to determine the effectiveness of plasma exchange (PE) in reducing triglyceride levels during an acute attack of hyperlipidemic pancreatitis (HLP). Methods: A total of 8 hypertriglyceridemic patients with the complication of acute pancreatitis received one course of PE treatment for 2 consecutive daily sessions. Results: The respectivemean removal rates during a single PE for triglyceride, cholesterol, amylase, and lipase were 63.0%, 53.7%, 62.9%, and 68.8%, respectively. An additional one exchange increased the removal rate to 83.3%, 62.9%, 79.6%, and 80.4%, respectively. The triglyceride level dropped to below 1000 mg/dl in all but one after the first PE treatment. Hemolysis during PE was found in 2 out of total 16 sessions due to high transmembrane pressure. Regarding the PE-related complications using fresh frozen plasma as replacement fluid, eight events occurred. The clearance rates of triglyceride and cholesterol were significantly higher for baseline triglyceride level (p=0.0238) and baseline cholesterol level (p=0.0117), respectively. The earlier start of PE treatment correlated well the clearance of lipase and amylase (p=0.0062 and p=0.0413, correspondingly). Conclusion: A single PE treatment is an effective method to clear impurities from plasma for most HLP patients. Earlier start of PE treatment may provide more effective removal of pancreatic enzymes from the plasma. As compared to fresh frozen plasma, albumin solution seems to be the more safer replacement fluid used in the PE unless the coexistent coagulopathy is highly concerned. |
本系統中英文摘要資訊取自各篇刊載內容。